RNA-based Therapies Show Promise in Early Studies, ReCode Reports

Retrieved on: 2021-06-14 13:30:00

Tags for this article:

Click the tags to see associated articles and topics

RNA-based Therapies Show Promise in Early Studies, ReCode Reports. View article details on hiswai:

Excerpt

ReCode's mRNA replacement agent for CF, RTX0001, is designed to deliver to cells a working version of CFTR's messenger RNA molecule (mRNA), ...

Article found on: cysticfibrosisnewstoday.com